Prediabetes Market, By Treatment & Management, By Gender, By Age Group, By Distribution Channel, By Weight Category, By End User, By Geography

Description

Prediabetes Market is estimated to be valued at USD 8.81 Bn in 2025 and is expected to reach USD 15.10 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 8.81 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.10%	2032 Value Projection:	USD 15.10 Bn

The global prediabetes market represents a critical segment within the broader diabetes management ecosystem, addressing the growing prevalence of impaired glucose tolerance and elevated blood sugar levels that precede type 2 diabetes onset. Prediabetes, characterized by blood glucose levels higher than normal but not yet reaching diabetic thresholds, affects millions worldwide and serves as a crucial intervention window for preventing progression to full-blown diabetes.

The market encompasses diagnostic tools, therapeutic interventions, monitoring devices, and lifestyle management solutions specifically designed for prediabetic populations. With rising obesity rates, sedentary lifestyles, and aging demographics contributing to increased prediabetes prevalence, healthcare systems globally are prioritizing early detection and intervention strategies. The market's significance extends beyond immediate healthcare needs, encompassing long-term cost reduction through preventive care approaches. Key stakeholders include pharmaceutical companies developing glucose-lowering medications, medical device manufacturers creating continuous glucose monitoring systems, diagnostic laboratories offering screening tests, and digital health platforms providing lifestyle intervention programs. The prediabetes market's evolution reflects the healthcare industry's paradigm shift toward preventive medicine, emphasizing early intervention to reduce diabetes-related complications and healthcare expenditures while improving patient outcomes through timely identification and management of glucose metabolism disorders.

Market Dynamics

The global prediabetes market experiences robust growth, driven by several interconnected factors that collectively propel market expansion and innovation. Primary drivers include the escalating global prevalence of prediabetes, with an estimated 374 million adults worldwide living with impaired glucose tolerance, creating substantial demand for diagnostic and therapeutic solutions. Increasing healthcare awareness campaigns and government initiatives promoting early diabetes screening contribute significantly to market growth, as do technological advancements in non-invasive glucose monitoring devices and digital health platforms that enhance patient engagement and monitoring capabilities. However, the market faces notable restraints including limited healthcare infrastructure in developing regions, high costs associated with continuous glucose monitoring systems, and insufficient reimbursement coverage for prediabetes management programs in many healthcare systems.

Additionally, patient compliance challenges with lifestyle modifications and medication adherence present ongoing obstacles to market penetration. Despite these constraints, substantial opportunities emerge through the development of personalized medicine approaches utilizing genetic testing and biomarker identification for tailored prediabetes interventions. The integration of artificial intelligence and machine learning in predictive analytics for diabetes risk assessment opens new market avenues, while expanding telemedicine capabilities and remote patient monitoring solutions address geographical barriers to care access. Furthermore, pharmaceutical companies' increasing focus on developing novel therapeutic agents specifically targeting prediabetic populations, combined with growing corporate wellness programs emphasizing preventive healthcare, creates additional market opportunities for stakeholders across the prediabetes management spectrum.

Key Features of the Study

This report provides an in-depth analysis of the global prediabetes market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global prediabetes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bristol-Myers Squibb, Mylan Pharmaceuticals, Teva Pharmaceuticals, Sun Pharmaceutical Industries, Sandoz (Novartis), Glenmark, Dexcom, Abbott Laboratories, Medtronic, Ascensia Diabetes Care, Senseonics, Herbalife Nutrition, Nestle Health Science, and Danone
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global prediabetes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prediabetes market

Market Segmentation

Treatment & Management Insights (Revenue, USD Bn, 2020 - 2032)
- Metformin
- Digital Health and Wearables
- Glucose Monitoring Devices (CGM, BGM)
- Herbal Supplements
- Others (Probiotics and Gut Health Products, etc.)
Gender Insights (Revenue, USD Bn, 2020 - 2032)
- Male
- Female
Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Adult
- Pediatric
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Online
- Offline
- Specialty Pharmacies and Drugstores
- Supermarkets or Hypermarkets
Weight Category Insights (Revenue, USD Bn, 2020 - 2032)
- Overweight and Obese Individuals (Primary Target)
- Normal Weight with Metabolic Risk (Underdiagnosed Segment)
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Diagnostic Laboratories
- Home Care Settings
- Specialty Clinics
- Health and Wellness Centers
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Bristol-Myers Squibb
- Mylan Pharmaceuticals
- Teva Pharmaceuticals
- Sun Pharmaceutical Industries
- Sandoz (Novartis)
- Glenmark
- Dexcom
- Abbott Laboratories
- Medtronic
- Ascensia Diabetes Care
- Senseonics
- Herbalife Nutrition
- Nestle Health Science
- Danone

Product Code: CMI8058

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Prediabetes Market, By Treatment & Management
- Global Prediabetes Market, By Gender
- Global Prediabetes Market, By Age Group
- Global Prediabetes Market, By Distribution Channel
- Global Prediabetes Market, By Weight Category
- Global Prediabetes Market, By End User
- Global Prediabetes Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Prediabetes Market, By Treatment & Management, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Metformin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Digital Health and Wearables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Glucose Monitoring Devices (CGM, BGM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Herbal Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Probiotics and Gut Health Products, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Prediabetes Market, By Gender, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Prediabetes Market, By Age Group, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Prediabetes Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Online
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Offline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Specialty Pharmacies and Drugstores
  - Supermarkets or Hypermarkets

8. Global Prediabetes Market, By Weight Category, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Overweight and Obese Individuals (Primary Target)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Normal Weight with Metabolic Risk (Underdiagnosed Segment)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Prediabetes Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Health and Wellness Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Prediabetes Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Treatment & Management, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Weight Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Treatment & Management, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Weight Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Treatment & Management, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Weight Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Treatment & Management, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Weight Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Treatment & Management, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Weight Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Treatment & Management, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Weight Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive Landscape

Bristol-Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mylan Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sun Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sandoz (Novartis)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Glenmark
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Dexcom
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ascensia Diabetes Care
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Senseonics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Herbalife Nutrition
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nestle Health Science
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Danone
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

12. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

13. References and Research Methodology

References
Research Methodology
About us